A frothy SPAC market and a damning article clued short seller Spruce Point Capital in on its newest target: bioplastics company Danimer
Danimer Scientific has numerous red flags, according to short-seller Ben Axler. The bioplastics company was taken public in a $525 million SPAC deal at the end of 2020. “No one has done this at scale,” Axler told Insider about the company’s business. See more stories on Insider’s business page. Spruce Point Capital, the $226 million short-seller run by Ben Axler, […]
Read more